Broad genomic testing linked to longer survival in advanced lung cancer, according to new study

Medical Xpress - latest medical and health news stories · 41m ago

New research in the November 2026 issue of Journal of the National Comprehensive Cancer Network found that patients with advanced non-small cell lung cancer (NSCLC) lived longer when they received broad-based genomic sequencing (BGS)—testing a large panel of dozens or hundreds of genes at once—before starting treatment, compared with patients who received more limited biomarker testing of just…

Read original article on Medical Xpress - latest medical and health news stories →

Broad genomic testing linked to longer survival in advanced lung cancer, according to new study

Related news